Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.39 USD | +1.12% | +3.24% | +10.42% |
Dec. 16 | Latecoere: Yves Yemsi appointed Director of Operations | CF |
Dec. 16 | Latecoere Appoints Yves Yemsi as Group Chief Operating Officer & President EMEA, Effective February 1, 2025 | CI |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.9 | 3.79 | 3.51 | 3.72 | 3.24 | |||||
Return on Total Capital | 6.37 | 7.87 | 7.26 | 7.86 | 6.68 | |||||
Return On Equity % | 3.02 | 19.56 | 24.6 | 20.84 | 15.81 | |||||
Return on Common Equity | 3.02 | 19.56 | 24.75 | 16.73 | 11.86 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 6.31 | 7.36 | 7.48 | 7.54 | 7.65 | |||||
SG&A Margin | 3.45 | 3.39 | 3.43 | 3.28 | 3.49 | |||||
EBITDA Margin % | 4.61 | 5.72 | 5.62 | 5.64 | 5.87 | |||||
EBITA Margin % | 2.87 | 3.97 | 4.05 | 4.28 | 4.24 | |||||
EBIT Margin % | 2.6 | 3.71 | 3.79 | 3.99 | 3.89 | |||||
Income From Continuing Operations Margin % | 0.36 | 2.54 | 3.61 | 3.4 | 3.3 | |||||
Net Income Margin % | 0.36 | 2.54 | 3.59 | 2.61 | 3.81 | |||||
Net Avail. For Common Margin % | 0.36 | 2.54 | 3.59 | 2.61 | 2.4 | |||||
Normalized Net Income Margin | 1.24 | 2.08 | 2.13 | 1.27 | 1.08 | |||||
Levered Free Cash Flow Margin | 2.55 | -1.68 | 0.72 | 0.68 | 3.1 | |||||
Unlevered Free Cash Flow Margin | 2.91 | -1.29 | 1.09 | 1.15 | 3.59 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.78 | 1.63 | 1.48 | 1.49 | 1.33 | |||||
Fixed Assets Turnover | 9.39 | 8.68 | 9.47 | 10.61 | 9.08 | |||||
Receivables Turnover (Average Receivables) | 8.29 | 6.93 | 6.41 | 7.43 | 7.54 | |||||
Inventory Turnover (Average Inventory) | 6.04 | 5.82 | 4.6 | 3.98 | 3.59 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.26 | 1.45 | 1.34 | 1.48 | 1.52 | |||||
Quick Ratio | 0.64 | 0.88 | 0.64 | 0.7 | 0.67 | |||||
Operating Cash Flow to Current Liabilities | -0.21 | 0.02 | 0.1 | 0.09 | 0.16 | |||||
Days Sales Outstanding (Average Receivables) | 44.14 | 52.65 | 56.98 | 49.13 | 48.53 | |||||
Days Outstanding Inventory (Average Inventory) | 60.58 | 62.71 | 79.34 | 91.78 | 101.97 | |||||
Average Days Payable Outstanding | 82.52 | 84.14 | 78.38 | 76.65 | 80.35 | |||||
Cash Conversion Cycle (Average Days) | 22.2 | 31.22 | 57.95 | 64.26 | 70.15 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 123.99 | 130.58 | 116.1 | 78.43 | 73.01 | |||||
Total Debt / Total Capital | 55.35 | 56.63 | 53.73 | 43.95 | 42.2 | |||||
LT Debt/Equity | 114.27 | 118.77 | 90.35 | 73.57 | 70.44 | |||||
Long-Term Debt / Total Capital | 51.01 | 51.51 | 41.81 | 41.23 | 40.71 | |||||
Total Liabilities / Total Assets | 79.32 | 78.3 | 78.23 | 73.33 | 70.83 | |||||
EBIT / Interest Expense | 4.54 | 5.97 | 6.45 | 5.24 | 4.97 | |||||
EBITDA / Interest Expense | 9.22 | 10.4 | 10.75 | 8.21 | 8.4 | |||||
(EBITDA - Capex) / Interest Expense | 5.89 | 8.06 | 7.85 | 5.46 | 5.84 | |||||
Total Debt / EBITDA | 2.74 | 2.88 | 2.97 | 2.36 | 2.24 | |||||
Net Debt / EBITDA | 1.24 | 1.19 | 1.17 | 0.62 | 0.81 | |||||
Total Debt / (EBITDA - Capex) | 4.29 | 3.71 | 4.07 | 3.55 | 3.22 | |||||
Net Debt / (EBITDA - Capex) | 1.94 | 1.53 | 1.6 | 0.94 | 1.17 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -7.63 | -0.36 | 7.95 | 16.53 | -7.32 | |||||
Gross Profit, 1 Yr. Growth % | -5.47 | 12.27 | 9.69 | 17.51 | 1.05 | |||||
EBITDA, 1 Yr. Growth % | 1.78 | 18.02 | 6.1 | 17.03 | 0.39 | |||||
EBITA, 1 Yr. Growth % | 4.61 | 28.2 | 10.14 | 23.16 | -0.97 | |||||
EBIT, 1 Yr. Growth % | 6.93 | 31.19 | 10.16 | 22.7 | -1.53 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -6.23 | 596.59 | 53.34 | 9.89 | 27.67 | |||||
Net Income, 1 Yr. Growth % | -6.23 | 596.59 | 52.69 | -15.28 | 26.86 | |||||
Normalized Net Income, 1 Yr. Growth % | 19.6 | 51.07 | 10.61 | -41.61 | 1.91 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -4.17 | 611.76 | 60.33 | -11.34 | 49.02 | |||||